HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY (HIVEC (R)) WITH ENDOVESICAL MMC IN PATIENTS WITH INTERMEDIATE- AND HIGH-RISK NMIBC NOT RESPONSIVE OR INTOLERANT TO BCG: OUR FIRST EXPERIENCE
ANTICANCER RESEARCH（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要